Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNaked Wine Regulatory News (WINE)

Share Price Information for Naked Wine (WINE)

Share Price is delayed by 15 minutes
Get Live Data
74.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.80 (2.493%)
Market Cap: £49.49m
WINE Live PriceLast checked at - London Stock Exchange

Intraday Naked Wine Share Chart

Board Changes

20 Feb 2018 07:00

RNS Number : 1359F
Majestic Wine PLC
20 February 2018
 

Majestic Wine PLC

(the "Company")

 

Board Changes

20 February 2018

 

Majestic Wine PLC announces today that Anita Balchandani, Independent Non-Executive Director and Chair of the Remuneration Committee, has informed the Company that, as a consequence of her joining McKinsey & Company as a full-time Partner, she is required to step down from her appointment with the Company and will do so after the Board meeting on March 14 2018.

Since joining the Company in June 2015, Anita has provided valuable insight to support shaping the strategy for the business as well as development of the Company's remuneration structure and share incentive schemes. The Board wishes to thank Anita for the dedication, passion and enthusiasm she has given the Company over her tenure and wishes her every success in her new role. Ian Harding, Senior Independent Director and Chair of the Audit Committee, will be replacing Anita Balchandani as Chair of the Remuneration Committee with immediate effect. Following the approval and release of the Company's full year results in June 2019 Ian will hand over the role of Chair of the Audit Committee to David Stead who joined the Board in November 2017 as an independent Non-Executive Director.

 

About the Directors

 

Ian Harding joined the Board as an independent Non-Executive Director on 1 June 2013 and has been Chair of the Audit Committee and a member of the Remuneration Committee and Nomination Committee since that date. He became Senior Independent Director on 15 June 2017. He is a chartered accountant and spent 16 years in various finance and auditing roles at PwC, Superdrug PLC and Kingfisher PLC. In 2001 he became Kingfisher's Investor Relations Director and went on to hold several senior roles on the executive committee including Communications Director and latterly Special Advisor to the Board.

 

David Stead joined the Board as an Independent Non-Executive Director on 1 November 2017 and is a member of the Company's Audit, Nomination and Remuneration Committees. David is currently Non-Executive Director and Chair of the Audit Committee of Card Factory plc and Joules Group plc. He is also a member of the Council at the University of Birmingham. David was Chief Financial Officer of Dunelm Group plc from September 2003 until his retirement in 2015. Prior to this, David was Finance Director for Boots The Chemists Ltd and Boots Healthcare International between 1991 and 2003. David is a chartered accountant, having spent the early part of his career with KPMG.

 

For further information, please contact:

Majestic Wine PLC

Rowan Gormley, Chief Executive Officer

James Crawford, Chief Financial Officer

Gabriella Clinkard, Public & Investor Relations

 

Tel: 01923 298 200

 

 

Tel: 07891 206239

gabby.clinkard@majestic.co.uk

 

Investec (NOMAD & Joint Broker)

Garry Levin / David Flin / David Anderson/Carlton Nelson

 

Tel: 0207 597 5970

 

Liberum (Joint Broker)

Peter Tracey / Richard Bootle

 

Tel: 020 3100 2222

 

Instinctif Partners (PR Agency)

Damian Reece

 

 

Tel: 0207 457 2020

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOATFMMTMBJBBBP
Date   Source Headline
11th Jun 202510:00 amRNSDirector/PDMR Shareholding
9th Jun 202511:55 amRNSDirector/PDMR Shareholding
20th May 20251:20 pmRNSDirector/PDMR Shareholding
19th May 20252:05 pmRNSHolding(s) in Company
12th May 202512:10 pmRNSDirector/PDMR Shareholding
29th Apr 202510:10 amRNSDirector/PDMR Shareholding
25th Apr 20257:00 amRNSPre-Close Trading Update
16th Apr 20255:10 pmRNSHolding(s) in Company
4th Apr 202512:40 pmRNSHolding(s) in Company
3rd Apr 20257:00 amRNSHolding(s) in Company
31st Mar 20258:33 amRNSHolding(s) in Company
31st Mar 20257:00 amRNSDirectorate Change
28th Mar 202512:30 pmRNS-RStrategy Event Materials
27th Mar 20257:00 amRNSNew Strategic Plan
7th Mar 20257:00 amRNSAppointment of Joint Broker
4th Mar 202510:10 amRNSHolding(s) in Company
3rd Mar 20257:00 amRNSStrategy Event and IMC Presentation
29th Jan 20257:00 amRNSPeak Season Trading Update
27th Jan 202511:50 amRNSHolding(s) in Company
7th Jan 20259:15 amRNSHolding(s) in Company
31st Dec 20248:15 amRNSHolding(s) in Company
10th Dec 20247:00 amRNSHalf-year Report
5th Dec 20242:45 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSConfirmation of Half Year Results Release Date
6th Nov 20247:00 amRNSBlock Listing Six Monthly Return
11th Oct 20248:30 amRNSDirector/PDMR Shareholding
30th Sep 20245:24 pmRNSResult of AGM
30th Sep 20245:23 pmRNSDirectorate Change
5th Sep 20242:10 pmRNSDirector/PDMR Shareholding
4th Sep 20244:25 pmRNSDirector/PDMR Shareholding
4th Sep 20244:15 pmRNSHolding(s) in Company
4th Sep 20247:00 amRNSAGM and Annual Report and Accounts
28th Aug 20247:01 amRNSAppointment of Chief Financial Officer
28th Aug 20247:00 amRNSFinal Results
23rd Aug 20247:00 amRNSConfirmation of Full Year Results Release Date
13th Aug 202410:10 amRNSHolding(s) in Company
18th Jul 202410:45 amRNSHolding(s) in Company
16th Jul 20243:39 pmRNSHolding(s) in Company
9th Jul 20247:01 amRNSCFO Succession Plan
9th Jul 20247:00 amRNSCompletion of new $60m credit facility
24th May 20245:45 pmRNSHolding(s) in Company
22nd May 20241:15 pmRNSHolding(s) in Company
22nd May 20248:30 amRNSDirector/PDMR Shareholding
21st May 20249:30 amRNSHolding(s) in Company
21st May 20247:00 amRNSPre-Close Trading Update
9th May 20247:00 amRNSBlock Listing Six Monthly Return
7th May 202410:15 amRNSHolding(s) in Company
1st May 202410:35 amRNSDirector/PDMR Shareholding
2nd Apr 20247:01 amRNSGrant of LTIP awards
2nd Apr 20247:00 amRNSAppointment of Rodrigo Maza as CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.